Congratulations to CCS researchers named in The Australian's top 250

L-R: Professor Natasha Lannin has been nominated a global leader in
Rehabilitation Therapy, Professor Paul Myles a top researcher in the field of
Anesthesiology and Emeritus Professor Jeffrey Rosenfeld in Neurosurgery
in The Australian's RESEARCH 2021 List.

The Australian’s Research magazine takes a deep dive into Australian research, revealing its excellence in The List (published November 10, 2021). Congratulations to our researchers - see detail below.

The authors, Tim Dodd and Paul McCarthy, write, "Not for many decades has the value of research been so clear. Less than two years after the appearance of a new and dangerous virus, and thanks to countless researchers in infectious disease, immunology, epidemiology and other fields, we now have many effective vaccines in mass production, and numerous tests and treatments for Covid-19.

"In The Australian’s annual Research magazine, we acknowledge the talent and dedication of our researchers. And again, as we have for the previous four years, we present The List – a roll call of the best researchers and the best research institutions in Australia in 250 individual fields of research."

New efforts to broaden PhD training are “fantastic” but Australian medical industry needs capitalisation

Fabienne Mackay says the medical industry hasn’t
been supported enough.
Picture: Aaron FrancisSource: News Corp Australia

The Australian published an article (18/2/2015) quoting Professors Stephen Jane and Fabienne Mackay on medical research PhD training and post PhD opportunities. Link. Excerpts quoted below.

"Monash University’s Central Clinical School head, Stephen Jane, said the new PhD ... included content on intellectual property, designing clinical trials and statistics. He said the PhD would arm students with 'a skill set commensurate with a far broader range of career options but also emphasise the necessity to engage with industry'.

"...for leading medical researcher Fabienne Mackay, head of the department of immunology at Monash University, the real problem is that Australia’s medical industry hasn’t been supported enough to grow to the scale the country needs to capitalise on its strong medical research. She said the US was also facing an oversupply of medical researchers but, unlike Australia, there was a big medical industry to soak them up.

“'The real problem does not come from universities who develop links with national and international industry partners to create opportunities for their students and the workforce. The problem is the choice made by leaders of this nation who have neglected efforts to diversify our economy and never made the choice to exploit homegrown talents to build a decent homegrown medical industry,' she said."